Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3
Authors
Keywords
Antibodies, Recombinant proteins, Enzyme-linked immunoassays, Immunologic adjuvants, Plasmodium, Antigens, Malaria, Alumni
Journal
PLoS One
Volume 8, Issue 2, Pages e56061
Publisher
Public Library of Science (PLoS)
Online
2013-02-15
DOI
10.1371/journal.pone.0056061
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of the genetic variability of PvMSP-3α among Plasmodium vivax in Brazilian field isolates
- (2014) Ricardo Souza Ribeiro et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-119 and PvMSP-3α359−798) and their relationship with hematological features in malaria patients from the Brazilian Amazon
- (2012) Luiza Carvalho Mourão et al. MICROBES AND INFECTION
- Evaluation of the Naturally Acquired Antibody Immune Response to the Pv200L N-terminal Fragment of Plasmodium vivax Merozoite Surface Protein-1 in Four Areas of the Amazon Region of Brazil
- (2011) Luciane M. Storti-Melo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Phase I Safety and Immunogenicity Trial of Plasmodium vivax CS Derived Long Synthetic Peptides Adjuvanted with Montanide ISA 720 or Montanide ISA 51
- (2011) Sócrates Herrera et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Antibody-Mediated and Cellular Immune Responses Induced in Naive Volunteers by Vaccination with Long Synthetic Peptides Derived from the Plasmodium vivax Circumsporozoite Protein
- (2011) Myriam Arévalo-Herrera et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Long-Term Humoral and Cellular Immune Responses Elicited by a Heterologous Plasmodium vivax Apical Membrane Antigen 1 Protein Prime/Adenovirus Boost Immunization Protocol
- (2011) Leoneide Érica Maduro Bouillet et al. INFECTION AND IMMUNITY
- Protection against Malaria by MSP3 Candidate Vaccine
- (2011) Sodiomon B. Sirima et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- A Field Trial to Assess a Blood-Stage Malaria Vaccine
- (2011) Mahamadou A. Thera et al. NEW ENGLAND JOURNAL OF MEDICINE
- B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax Merozoite Surface Protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon
- (2011) J.C. Lima-Junior et al. VACCINE
- A Research Agenda for Malaria Eradication: Vaccines
- (2011) PLOS MEDICINE
- Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP142-C1/Alhydrogel with and without CPG 7909 in Malaria Naïve Adults
- (2010) Ruth D. Ellis et al. PLoS One
- A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice
- (2010) Fernanda Gentil et al. VACCINE
- Naturally acquired inhibitory antibodies toPlasmodium vivaxDuffy binding protein are short-lived and allele-specific following a single malaria infection
- (2009) I. P. Ceravolo et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Adjuvants for malaria vaccines
- (2009) R. N. COLER et al. PARASITE IMMUNOLOGY
- A Conserved Multi-Gene Family Induces Cross-Reactive Antibodies Effective in Defense against Plasmodium falciparum
- (2009) Subhash Singh et al. PLoS One
- A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel®+CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults
- (2009) Issaka Sagara et al. VACCINE
- The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali
- (2009) Boubacar Traore et al. VACCINE
- Biophysical characterization of the recombinant merozoite surface protein-3 of Plasmodium vivax
- (2008) M JIMENEZ et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Comparative genomics of the neglected human malaria parasite Plasmodium vivax
- (2008) Jane M. Carlton et al. NATURE
- Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
- (2008) Yimin Wu et al. PLoS One
- Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria
- (2008) Gregory E. D. Mullen et al. PLoS One
- New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin
- (2008) Daniel Y. Bargieri et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More